THEBAINE O-DEMETHYLATION TO ORIPAVINE - GENETIC-DIFFERENCES BETWEEN 2 RAT STRAINS

被引:27
作者
MIKUS, G
SOMOGYI, AA
BOCHNER, F
EICHELBAUM, M
机构
[1] DR MARGARETE FISCHER BOSCH INST CLIN PHARMACOL,W-7000 STUTTGART 50,GERMANY
[2] ROYAL ADELAIDE HOSP,DEPT CLIN PHARMACOL,ADELAIDE,SA 5000,AUSTRALIA
基金
英国医学研究理事会;
关键词
D O I
10.3109/00498259109044400
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. Codeine O-demethylation to morphine is mediated by cytochrome P450 IID1 (rat), or P450 IID6 (man), and exhibits genetic polymorphism. Thebaine is a precursor in the formation of endogenous morphine and codeine in man, being O-demethylated to oripavine. 2. The objective of the present study was to ascertain whether the O-demethylation of thebaine to oripavine was mediated by cytochrome P450 IID1 in rat liver microsomes. 3. Thebaine O-demethylation showed strain differences in female Sprague-Dawley (SD) and female Dark-Agouti (DA) rats, which serve as a model for the human debrisoquine/sparteine metabolism phenotypes. 4. The total intrinsic clearance of thebaine to oripavine was high (19.7 ml/h per mg protein) in SD rats, indicating that oripavine is a major metabolite of thebaine. A 3-fold lower intrinsic clearance was observed in DA rats (6.7 ml/h per mg protein). 5. Thebaine O-demethylation was inhibited by quinine and known substrates of cytochrome P450 IID1/P450 IID6, supporting the major involvement of cytochrome P450 IID1 in oripavine formation in rats.
引用
收藏
页码:1501 / 1509
页数:9
相关论文
共 33 条
[1]   ANIMAL MODELING OF HUMAN POLYMORPHIC DRUG OXIDATION - THE METABOLISM OF DEBRISOQUINE AND PHENACETIN IN RAT INBRED STRAINS [J].
ALDABBAGH, SG ;
IDLE, JR ;
SMITH, RL .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1981, 33 (03) :161-164
[2]   BUFURALOL 1'-HYDROXYLASE ACTIVITY OF THE RAT - STRAIN DIFFERENCES AND THE EFFECTS OF INHIBITORS [J].
BOOBIS, AR ;
SEDDON, CE ;
DAVIES, DS .
BIOCHEMICAL PHARMACOLOGY, 1986, 35 (17) :2961-2965
[3]  
BROCHMANN-HANSSEN E, 1984, Planta Medica, V51, P343
[4]  
BROCHMANNHANSSE.E, 1985, CHEM BIOL ISOQUINOLI, P229
[5]   MORPHINE AND CODEINE ARE ENDOGENOUS COMPONENTS OF HUMAN CEREBROSPINAL-FLUID [J].
CARDINALE, GJ ;
DONNERER, J ;
FINCK, AD ;
KANTROWITZ, JD ;
OKA, K ;
SPECTOR, S .
LIFE SCIENCES, 1987, 40 (03) :301-306
[6]   DISPOSITION AND METABOLISM OF CODEINE AFTER SINGLE AND CHRONIC DOSES IN ONE POOR AND 7 EXTENSIVE METABOLIZERS [J].
CHEN, ZR ;
SOMOGYI, AA ;
REYNOLDS, G ;
BOCHNER, F .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (04) :381-390
[7]  
CHEN ZR, 1988, LANCET, V2, P914
[8]   BIOACTIVATION OF THE NARCOTIC DRUG CODEINE IN HUMAN-LIVER IS MEDIATED BY THE POLYMORPHIC MONOOXYGENASE CATALYZING DEBRISOQUINE 4-HYDROXYLATION (CYTOCHROME-P-450 DBL/BUFI) [J].
DAYER, P ;
DESMEULES, J ;
LEEMANN, T ;
STRIBERNI, R .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 152 (01) :411-416
[9]   PRESENCE AND FORMATION OF CODEINE AND MORPHINE IN THE RAT [J].
DONNERER, J ;
OKA, K ;
BROSSI, A ;
RICE, KC ;
SPECTOR, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (12) :4566-4567
[10]  
DONNERER J, 1987, J PHARMACOL EXP THER, V242, P583